BackLi Kang Biomedical , Ltd. Overview

Li Kang Biomedical , Ltd. Accounts Payable

Li Kang Biomedical , Ltd.'s accounts payable is $25M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$25.16M
↑ 70.93% YoYΔ $10.44M vs prior year quarter

Peer trimmed avg / median

Loading

Li Kang Biomedical , Ltd. Accounts Payable History

Loading

Li Kang Biomedical , Ltd. vs. peers: Accounts Payable Comparison

Loading

Li Kang Biomedical , Ltd. Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Li Kang Biomedical , Ltd. (6242.TWO) FAQ

Li Kang Biomedical , Ltd. (6242.TWO) currently reports a accounts payable of $25M as of June 2026. That compares with $15M in the prior-year period — up 70.9% year over year. Use the charts on this page to explore Li Kang Biomedical , Ltd.'s accounts payable history and peer comparisons.

Li Kang Biomedical , Ltd.'s accounts payable increased from $15M to $25M — a 70.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Li Kang Biomedical , Ltd. reported $25M in accounts payable as of June 2026. That compares with $15M in the prior-year period — up 70.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $25M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Li Kang Biomedical , Ltd., and consider following 6242.TWO for alerts when major investors trade the stock.